1. Home
  2. NVCR vs CCU Comparison

NVCR vs CCU Comparison

Compare NVCR & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CCU
  • Stock Information
  • Founded
  • NVCR 2000
  • CCU 1850
  • Country
  • NVCR Switzerland
  • CCU Chile
  • Employees
  • NVCR N/A
  • CCU N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CCU Beverages (Production/Distribution)
  • Sector
  • NVCR Health Care
  • CCU Consumer Staples
  • Exchange
  • NVCR Nasdaq
  • CCU Nasdaq
  • Market Cap
  • NVCR 1.9B
  • CCU 2.4B
  • IPO Year
  • NVCR 2015
  • CCU 1992
  • Fundamental
  • Price
  • NVCR $17.60
  • CCU $12.83
  • Analyst Decision
  • NVCR Buy
  • CCU Strong Sell
  • Analyst Count
  • NVCR 7
  • CCU 2
  • Target Price
  • NVCR $32.43
  • CCU $9.70
  • AVG Volume (30 Days)
  • NVCR 1.4M
  • CCU 224.0K
  • Earning Date
  • NVCR 07-24-2025
  • CCU 08-06-2025
  • Dividend Yield
  • NVCR N/A
  • CCU 2.13%
  • EPS Growth
  • NVCR N/A
  • CCU 67.38
  • EPS
  • NVCR N/A
  • CCU 0.47
  • Revenue
  • NVCR $621,711,000.00
  • CCU $3,126,996,945.00
  • Revenue This Year
  • NVCR $5.56
  • CCU $9.09
  • Revenue Next Year
  • NVCR $9.19
  • CCU $4.83
  • P/E Ratio
  • NVCR N/A
  • CCU $13.89
  • Revenue Growth
  • NVCR 18.27
  • CCU 15.38
  • 52 Week Low
  • NVCR $14.17
  • CCU $10.00
  • 52 Week High
  • NVCR $34.13
  • CCU $15.75
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 49.74
  • CCU 43.52
  • Support Level
  • NVCR $16.81
  • CCU $12.82
  • Resistance Level
  • NVCR $18.59
  • CCU $13.60
  • Average True Range (ATR)
  • NVCR 0.74
  • CCU 0.33
  • MACD
  • NVCR 0.08
  • CCU 0.06
  • Stochastic Oscillator
  • NVCR 56.18
  • CCU 40.71

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CCU Compania Cervecerias Unidas S.A.

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

Share on Social Networks: